Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Non-Current Debt: 2010-2025

Historic Non-Current Debt for Cumberland Pharmaceuticals (CPIX) over the last 14 years, with Sep 2025 value amounting to $5.2 million.

  • Cumberland Pharmaceuticals' Non-Current Debt fell 48.13% to $5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year decrease of 48.13%. This contributed to the annual value of $10.2 million for FY2024, which is 20.40% down from last year.
  • Per Cumberland Pharmaceuticals' latest filing, its Non-Current Debt stood at $5.2 million for Q3 2025, which was down 0.00% from $5.2 million recorded in Q2 2025.
  • Cumberland Pharmaceuticals' 5-year Non-Current Debt high stood at $20.0 million for Q1 2022, and its period low was $5.2 million during Q1 2025.
  • In the last 3 years, Cumberland Pharmaceuticals' Non-Current Debt had a median value of $12.8 million in 2023 and averaged $11.2 million.
  • In the last 5 years, Cumberland Pharmaceuticals' Non-Current Debt surged by 35.71% in 2022 and then crashed by 67.43% in 2025.
  • Quarterly analysis of 5 years shows Cumberland Pharmaceuticals' Non-Current Debt stood at $15.0 million in 2021, then rose by 8.00% to $16.2 million in 2022, then decreased by 21.09% to $12.8 million in 2023, then declined by 20.40% to $10.2 million in 2024, then plummeted by 48.13% to $5.2 million in 2025.
  • Its Non-Current Debt stands at $5.2 million for Q3 2025, versus $5.2 million for Q2 2025 and $5.2 million for Q1 2025.